Structure

Physi-Chem Properties

Molecular Weight:  363.14
Volume:  382.464
LogP:  4.581
LogD:  4.522
LogS:  -4.863
# Rotatable Bonds:  2
TPSA:  60.68
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  6
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.404
Synthetic Accessibility Score:  2.705
Fsp3:  0.042
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.072
MDCK Permeability:  5.064109245722648e-06
Pgp-inhibitor:  0.874
Pgp-substrate:  0.981
Human Intestinal Absorption (HIA):  0.061
20% Bioavailability (F20%):  0.973
30% Bioavailability (F30%):  0.986

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.064
Plasma Protein Binding (PPB):  98.10330963134766%
Volume Distribution (VD):  1.059
Pgp-substrate:  1.591526746749878%

ADMET: Metabolism

CYP1A2-inhibitor:  0.488
CYP1A2-substrate:  0.695
CYP2C19-inhibitor:  0.968
CYP2C19-substrate:  0.733
CYP2C9-inhibitor:  0.948
CYP2C9-substrate:  0.988
CYP2D6-inhibitor:  0.75
CYP2D6-substrate:  0.869
CYP3A4-inhibitor:  0.94
CYP3A4-substrate:  0.768

ADMET: Excretion

Clearance (CL):  2.641
Half-life (T1/2):  0.3

ADMET: Toxicity

hERG Blockers:  0.049
Human Hepatotoxicity (H-HT):  0.512
Drug-inuced Liver Injury (DILI):  0.977
AMES Toxicity:  0.39
Rat Oral Acute Toxicity:  0.607
Maximum Recommended Daily Dose:  0.929
Skin Sensitization:  0.863
Carcinogencity:  0.061
Eye Corrosion:  0.003
Eye Irritation:  0.035
Respiratory Toxicity:  0.827

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC304203

Natural Product ID:  NPC304203
Common Name*:   2,2-Di(3-Indolyl)-3-Indolone
IUPAC Name:   2,2-bis(1H-indol-3-yl)-1H-indol-3-one
Synonyms:  
Standard InCHIKey:  IZKCVKAIVRRHDC-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C24H17N3O/c28-23-17-9-3-6-12-22(17)27-24(23,18-13-25-20-10-4-1-7-15(18)20)19-14-26-21-11-5-2-8-16(19)21/h1-14,25-27H
SMILES:  O=C1c2ccccc2NC1(c1c[nH]c2c1cccc2)c1c[nH]c2c1cccc2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL471481
PubChem CID:   10021609
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0002497] Indoles
          • [CHEMONTID:0004196] 3-alkylindoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[11076576]
NPO11616 Vibrio parahaemolyticus Species Vibrionaceae Bacteria n.a. North Sea n.a. PMID[14640534]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota Melia azedarach n.a. n.a. PMID[21353539]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[24183988]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[33180497]
NPO11616 Vibrio parahaemolyticus Species Vibrionaceae Bacteria n.a. n.a. n.a. PMID[7853008]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[8988601]
NPO11616 Vibrio parahaemolyticus Species Vibrionaceae Bacteria n.a. n.a. n.a. DOI[DOI: 10.1111/j.1574-6968.1992.tb05311.x]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11616 Vibrio parahaemolyticus Species Vibrionaceae Bacteria n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ = 11.0 mm PMID[508386]
NPT22368 ORGANISM Zika virus Zika virus EC50 = 22000.0 nM PMID[508387]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC304203 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9318 High Similarity NPC476460
0.924 High Similarity NPC284775
0.9 High Similarity NPC326422
0.887 High Similarity NPC477003
0.877 High Similarity NPC317701
0.8508 High Similarity NPC308931
0.8508 High Similarity NPC99939
0.8444 Intermediate Similarity NPC191415
0.8398 Intermediate Similarity NPC117027
0.8351 Intermediate Similarity NPC227582
0.8351 Intermediate Similarity NPC167710
0.8343 Intermediate Similarity NPC42372
0.8333 Intermediate Similarity NPC267811
0.8324 Intermediate Similarity NPC324091
0.8316 Intermediate Similarity NPC470702
0.8316 Intermediate Similarity NPC473218
0.8274 Intermediate Similarity NPC470703
0.8266 Intermediate Similarity NPC216643
0.8263 Intermediate Similarity NPC477004
0.8263 Intermediate Similarity NPC74413
0.822 Intermediate Similarity NPC252338
0.8207 Intermediate Similarity NPC133003
0.8202 Intermediate Similarity NPC471943
0.8197 Intermediate Similarity NPC102755
0.8172 Intermediate Similarity NPC473666
0.8167 Intermediate Similarity NPC293216
0.8135 Intermediate Similarity NPC260900
0.8112 Intermediate Similarity NPC116555
0.8111 Intermediate Similarity NPC252572
0.8034 Intermediate Similarity NPC115232
0.8021 Intermediate Similarity NPC67288
0.8021 Intermediate Similarity NPC131887
0.8012 Intermediate Similarity NPC288838
0.8011 Intermediate Similarity NPC92796
0.8011 Intermediate Similarity NPC135141
0.8 Intermediate Similarity NPC229893
0.799 Intermediate Similarity NPC82370
0.7979 Intermediate Similarity NPC321708
0.7977 Intermediate Similarity NPC53947
0.7947 Intermediate Similarity NPC47190
0.7946 Intermediate Similarity NPC470677
0.7923 Intermediate Similarity NPC151635
0.7921 Intermediate Similarity NPC36405
0.791 Intermediate Similarity NPC474492
0.7903 Intermediate Similarity NPC470205
0.7892 Intermediate Similarity NPC477042
0.7887 Intermediate Similarity NPC475914
0.7887 Intermediate Similarity NPC237414
0.7887 Intermediate Similarity NPC153123
0.7887 Intermediate Similarity NPC220797
0.7887 Intermediate Similarity NPC474318
0.7887 Intermediate Similarity NPC201266
0.7887 Intermediate Similarity NPC268744
0.7854 Intermediate Similarity NPC276657
0.7853 Intermediate Similarity NPC216550
0.7846 Intermediate Similarity NPC77241
0.7846 Intermediate Similarity NPC269203
0.7846 Intermediate Similarity NPC166209
0.7846 Intermediate Similarity NPC13456
0.7842 Intermediate Similarity NPC154339
0.7824 Intermediate Similarity NPC128244
0.7824 Intermediate Similarity NPC79356
0.7824 Intermediate Similarity NPC102592
0.7821 Intermediate Similarity NPC214106
0.782 Intermediate Similarity NPC267078
0.782 Intermediate Similarity NPC935
0.7783 Intermediate Similarity NPC474357
0.7766 Intermediate Similarity NPC110158
0.7765 Intermediate Similarity NPC100104
0.7765 Intermediate Similarity NPC470680
0.7722 Intermediate Similarity NPC242116
0.772 Intermediate Similarity NPC267343
0.7696 Intermediate Similarity NPC103119
0.7696 Intermediate Similarity NPC474412
0.7689 Intermediate Similarity NPC470323
0.7688 Intermediate Similarity NPC157583
0.7688 Intermediate Similarity NPC237188
0.7685 Intermediate Similarity NPC110182
0.7684 Intermediate Similarity NPC135601
0.7684 Intermediate Similarity NPC17273
0.7684 Intermediate Similarity NPC251391
0.7684 Intermediate Similarity NPC141612
0.768 Intermediate Similarity NPC271797
0.768 Intermediate Similarity NPC21174
0.768 Intermediate Similarity NPC265100
0.768 Intermediate Similarity NPC317105
0.7677 Intermediate Similarity NPC476073
0.7672 Intermediate Similarity NPC467063
0.7672 Intermediate Similarity NPC21429
0.767 Intermediate Similarity NPC471655
0.7654 Intermediate Similarity NPC76982
0.7653 Intermediate Similarity NPC34837
0.765 Intermediate Similarity NPC70949
0.7647 Intermediate Similarity NPC55772
0.7644 Intermediate Similarity NPC17059
0.7644 Intermediate Similarity NPC278434
0.7622 Intermediate Similarity NPC161861
0.7621 Intermediate Similarity NPC27041
0.7617 Intermediate Similarity NPC138370
0.7606 Intermediate Similarity NPC16659
0.7606 Intermediate Similarity NPC88110
0.7598 Intermediate Similarity NPC471194
0.7598 Intermediate Similarity NPC471193
0.7596 Intermediate Similarity NPC114637
0.7594 Intermediate Similarity NPC145885
0.7594 Intermediate Similarity NPC59269
0.7594 Intermediate Similarity NPC14113
0.7594 Intermediate Similarity NPC84827
0.759 Intermediate Similarity NPC157828
0.759 Intermediate Similarity NPC195239
0.759 Intermediate Similarity NPC202812
0.7584 Intermediate Similarity NPC325903
0.7581 Intermediate Similarity NPC469529
0.757 Intermediate Similarity NPC207686
0.7568 Intermediate Similarity NPC262338
0.7553 Intermediate Similarity NPC265710
0.7553 Intermediate Similarity NPC11126
0.7551 Intermediate Similarity NPC472293
0.7551 Intermediate Similarity NPC11445
0.7549 Intermediate Similarity NPC72956
0.7544 Intermediate Similarity NPC105127
0.7543 Intermediate Similarity NPC467188
0.7543 Intermediate Similarity NPC314372
0.7541 Intermediate Similarity NPC233380
0.7536 Intermediate Similarity NPC472285
0.7529 Intermediate Similarity NPC190296
0.7514 Intermediate Similarity NPC469780
0.7514 Intermediate Similarity NPC469767
0.7514 Intermediate Similarity NPC469761
0.7514 Intermediate Similarity NPC469783
0.7514 Intermediate Similarity NPC469784
0.7514 Intermediate Similarity NPC123906
0.7514 Intermediate Similarity NPC469768
0.7514 Intermediate Similarity NPC469779
0.7513 Intermediate Similarity NPC73994
0.7512 Intermediate Similarity NPC153980
0.7512 Intermediate Similarity NPC6865
0.75 Intermediate Similarity NPC473380
0.75 Intermediate Similarity NPC111275
0.75 Intermediate Similarity NPC240088
0.7487 Intermediate Similarity NPC472292
0.7487 Intermediate Similarity NPC110500
0.7487 Intermediate Similarity NPC149155
0.7487 Intermediate Similarity NPC228835
0.7487 Intermediate Similarity NPC203468
0.7486 Intermediate Similarity NPC274981
0.7485 Intermediate Similarity NPC96102
0.7477 Intermediate Similarity NPC101350
0.7472 Intermediate Similarity NPC24678
0.7472 Intermediate Similarity NPC105818
0.7471 Intermediate Similarity NPC469766
0.746 Intermediate Similarity NPC213468
0.746 Intermediate Similarity NPC283219
0.746 Intermediate Similarity NPC248041
0.746 Intermediate Similarity NPC126709
0.7459 Intermediate Similarity NPC78020
0.7458 Intermediate Similarity NPC105811
0.7457 Intermediate Similarity NPC73767
0.7457 Intermediate Similarity NPC110126
0.7454 Intermediate Similarity NPC70155
0.7451 Intermediate Similarity NPC162860
0.745 Intermediate Similarity NPC471944
0.7448 Intermediate Similarity NPC15102
0.7447 Intermediate Similarity NPC267885
0.7443 Intermediate Similarity NPC159856
0.7442 Intermediate Similarity NPC267853
0.7442 Intermediate Similarity NPC84911
0.7438 Intermediate Similarity NPC54420
0.7437 Intermediate Similarity NPC472296
0.7437 Intermediate Similarity NPC472297
0.7433 Intermediate Similarity NPC477611
0.7431 Intermediate Similarity NPC235685
0.743 Intermediate Similarity NPC70406
0.7423 Intermediate Similarity NPC255909
0.7421 Intermediate Similarity NPC314919
0.7418 Intermediate Similarity NPC80681
0.7416 Intermediate Similarity NPC264285
0.7409 Intermediate Similarity NPC94752
0.7409 Intermediate Similarity NPC62749
0.7409 Intermediate Similarity NPC235684
0.7407 Intermediate Similarity NPC244897
0.7405 Intermediate Similarity NPC56233
0.7404 Intermediate Similarity NPC322064
0.7404 Intermediate Similarity NPC471192
0.7398 Intermediate Similarity NPC272458
0.7389 Intermediate Similarity NPC259644
0.7389 Intermediate Similarity NPC73952
0.7389 Intermediate Similarity NPC469760
0.7389 Intermediate Similarity NPC469765
0.7389 Intermediate Similarity NPC25008
0.7389 Intermediate Similarity NPC175602
0.7389 Intermediate Similarity NPC469763
0.7389 Intermediate Similarity NPC469786
0.7387 Intermediate Similarity NPC171317
0.7384 Intermediate Similarity NPC261195
0.7384 Intermediate Similarity NPC29886
0.7383 Intermediate Similarity NPC192712
0.7381 Intermediate Similarity NPC269270
0.7374 Intermediate Similarity NPC313889
0.7374 Intermediate Similarity NPC473878

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC304203 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8352 Intermediate Similarity NPD3607 Clinical (unspecified phase)
0.828 Intermediate Similarity NPD6180 Clinical (unspecified phase)
0.8201 Intermediate Similarity NPD4848 Phase 1
0.8196 Intermediate Similarity NPD2008 Discontinued
0.8131 Intermediate Similarity NPD2411 Approved
0.8065 Intermediate Similarity NPD4426 Clinical (unspecified phase)
0.8031 Intermediate Similarity NPD8248 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD5473 Discontinued
0.7861 Intermediate Similarity NPD7564 Discontinued
0.7853 Intermediate Similarity NPD4922 Phase 2
0.7796 Intermediate Similarity NPD1291 Clinical (unspecified phase)
0.7796 Intermediate Similarity NPD2479 Phase 3
0.7796 Intermediate Similarity NPD2481 Approved
0.7778 Intermediate Similarity NPD5426 Phase 3
0.775 Intermediate Similarity NPD2509 Approved
0.775 Intermediate Similarity NPD2510 Approved
0.7713 Intermediate Similarity NPD3318 Approved
0.7713 Intermediate Similarity NPD3320 Approved
0.7713 Intermediate Similarity NPD3319 Phase 1
0.7688 Intermediate Similarity NPD6203 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD7618 Phase 3
0.768 Intermediate Similarity NPD7619 Phase 3
0.7677 Intermediate Similarity NPD2879 Approved
0.7677 Intermediate Similarity NPD2881 Approved
0.7662 Intermediate Similarity NPD2443 Approved
0.7662 Intermediate Similarity NPD2442 Approved
0.766 Intermediate Similarity NPD4011 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD4374 Clinical (unspecified phase)
0.7612 Intermediate Similarity NPD3905 Phase 3
0.76 Intermediate Similarity NPD5901 Discontinued
0.7586 Intermediate Similarity NPD7998 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD4051 Discontinued
0.7574 Intermediate Similarity NPD6459 Phase 2
0.7573 Intermediate Similarity NPD3393 Approved
0.7573 Intermediate Similarity NPD4851 Clinical (unspecified phase)
0.7573 Intermediate Similarity NPD3389 Approved
0.7573 Intermediate Similarity NPD3394 Approved
0.7551 Intermediate Similarity NPD1851 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD2121 Clinical (unspecified phase)
0.7549 Intermediate Similarity NPD4614 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD749 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD4075 Phase 2
0.7513 Intermediate Similarity NPD6595 Phase 3
0.7512 Intermediate Similarity NPD6987 Phase 1
0.7487 Intermediate Similarity NPD2091 Phase 2
0.7487 Intermediate Similarity NPD482 Approved
0.7487 Intermediate Similarity NPD2096 Phase 2
0.7486 Intermediate Similarity NPD2837 Discontinued
0.7485 Intermediate Similarity NPD198 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD6454 Clinical (unspecified phase)
0.7472 Intermediate Similarity NPD2172 Phase 1
0.7471 Intermediate Similarity NPD1722 Approved
0.7461 Intermediate Similarity NPD4988 Discontinued
0.7459 Intermediate Similarity NPD1343 Approved
0.7457 Intermediate Similarity NPD786 Approved
0.7451 Intermediate Similarity NPD2408 Discontinued
0.7451 Intermediate Similarity NPD1600 Suspended
0.7448 Intermediate Similarity NPD6610 Clinical (unspecified phase)
0.7437 Intermediate Similarity NPD7000 Clinical (unspecified phase)
0.7437 Intermediate Similarity NPD6999 Discontinued
0.7435 Intermediate Similarity NPD5728 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD2092 Phase 2
0.7435 Intermediate Similarity NPD2095 Phase 2
0.7435 Intermediate Similarity NPD2094 Phase 2
0.7426 Intermediate Similarity NPD6288 Clinical (unspecified phase)
0.7424 Intermediate Similarity NPD6664 Approved
0.7411 Intermediate Similarity NPD7024 Clinical (unspecified phase)
0.7406 Intermediate Similarity NPD7661 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD8000 Clinical (unspecified phase)
0.7366 Intermediate Similarity NPD7704 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD1270 Approved
0.7343 Intermediate Similarity NPD7454 Approved
0.7343 Intermediate Similarity NPD7455 Approved
0.732 Intermediate Similarity NPD6217 Discontinued
0.732 Intermediate Similarity NPD5820 Clinical (unspecified phase)
0.7318 Intermediate Similarity NPD3100 Discontinued
0.7308 Intermediate Similarity NPD6787 Phase 2
0.7302 Intermediate Similarity NPD5065 Approved
0.7297 Intermediate Similarity NPD3323 Discontinued
0.7296 Intermediate Similarity NPD1905 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD5069 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD6137 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD3947 Discontinued
0.725 Intermediate Similarity NPD2880 Discontinued
0.7243 Intermediate Similarity NPD1853 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD7666 Phase 3
0.7233 Intermediate Similarity NPD7665 Phase 2
0.7231 Intermediate Similarity NPD5809 Phase 3
0.7227 Intermediate Similarity NPD6986 Phase 1
0.722 Intermediate Similarity NPD7001 Phase 3
0.722 Intermediate Similarity NPD6732 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6446 Discontinued
0.7212 Intermediate Similarity NPD8013 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD3961 Discontinued
0.7192 Intermediate Similarity NPD5017 Discontinued
0.7184 Intermediate Similarity NPD8493 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD1506 Discontinued
0.7183 Intermediate Similarity NPD6242 Discontinued
0.7177 Intermediate Similarity NPD6954 Phase 2
0.7163 Intermediate Similarity NPD7809 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD750 Phase 2
0.715 Intermediate Similarity NPD6277 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD8464 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5888 Phase 2
0.7136 Intermediate Similarity NPD5198 Approved
0.7136 Intermediate Similarity NPD5199 Approved
0.7129 Intermediate Similarity NPD1982 Phase 1
0.7129 Intermediate Similarity NPD6152 Phase 1
0.7129 Intermediate Similarity NPD5475 Discontinued
0.7128 Intermediate Similarity NPD2642 Approved
0.7128 Intermediate Similarity NPD2639 Approved
0.7128 Intermediate Similarity NPD4643 Clinical (unspecified phase)
0.7112 Intermediate Similarity NPD3583 Phase 2
0.71 Intermediate Similarity NPD460 Discontinued
0.709 Intermediate Similarity NPD2185 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD4462 Approved
0.7088 Intermediate Similarity NPD4463 Approved
0.7073 Intermediate Similarity NPD4924 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD4524 Discontinued
0.7065 Intermediate Similarity NPD5853 Phase 3
0.7065 Intermediate Similarity NPD5855 Phase 3
0.7064 Intermediate Similarity NPD4845 Discontinued
0.7064 Intermediate Similarity NPD6165 Phase 2
0.7064 Intermediate Similarity NPD6164 Phase 2
0.7053 Intermediate Similarity NPD1573 Approved
0.7053 Intermediate Similarity NPD1575 Approved
0.7048 Intermediate Similarity NPD7470 Discontinued
0.7047 Intermediate Similarity NPD3505 Approved
0.7047 Intermediate Similarity NPD3506 Approved
0.7043 Intermediate Similarity NPD2213 Approved
0.7043 Intermediate Similarity NPD2214 Approved
0.7039 Intermediate Similarity NPD6176 Phase 1
0.7039 Intermediate Similarity NPD4637 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD7780 Approved
0.7032 Intermediate Similarity NPD7781 Approved
0.7031 Intermediate Similarity NPD4128 Approved
0.7031 Intermediate Similarity NPD4736 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD1895 Discontinued
0.7026 Intermediate Similarity NPD3178 Discontinued
0.7022 Intermediate Similarity NPD3943 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD8431 Approved
0.702 Intermediate Similarity NPD3486 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD6838 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD7594 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD4852 Phase 2
0.701 Intermediate Similarity NPD4076 Approved
0.701 Intermediate Similarity NPD7621 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD4079 Approved
0.701 Intermediate Similarity NPD2590 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD4299 Phase 1
0.7 Intermediate Similarity NPD2336 Approved
0.6995 Remote Similarity NPD5446 Phase 2
0.699 Remote Similarity NPD5106 Approved
0.699 Remote Similarity NPD5105 Approved
0.6982 Remote Similarity NPD8047 Clinical (unspecified phase)
0.6978 Remote Similarity NPD4547 Phase 3
0.6971 Remote Similarity NPD4862 Clinical (unspecified phase)
0.6968 Remote Similarity NPD5400 Approved
0.6963 Remote Similarity NPD5818 Discontinued
0.6963 Remote Similarity NPD4184 Clinical (unspecified phase)
0.6959 Remote Similarity NPD4181 Approved
0.6959 Remote Similarity NPD2753 Discontinued
0.6948 Remote Similarity NPD8112 Clinical (unspecified phase)
0.6943 Remote Similarity NPD4883 Approved
0.6935 Remote Similarity NPD4948 Discontinued
0.6935 Remote Similarity NPD5590 Clinical (unspecified phase)
0.6934 Remote Similarity NPD8458 Clinical (unspecified phase)
0.6934 Remote Similarity NPD8093 Discontinued
0.693 Remote Similarity NPD4429 Discontinued
0.6927 Remote Similarity NPD3609 Approved
0.6927 Remote Similarity NPD3610 Approved
0.6919 Remote Similarity NPD7825 Clinical (unspecified phase)
0.6915 Remote Similarity NPD1403 Approved
0.6915 Remote Similarity NPD5592 Clinical (unspecified phase)
0.6915 Remote Similarity NPD1404 Approved
0.6911 Remote Similarity NPD2641 Approved
0.6911 Remote Similarity NPD2640 Approved
0.6911 Remote Similarity NPD1292 Clinical (unspecified phase)
0.6907 Remote Similarity NPD3238 Discontinued
0.6906 Remote Similarity NPD5254 Discontinued
0.6906 Remote Similarity NPD7790 Approved
0.6906 Remote Similarity NPD7952 Approved
0.6906 Remote Similarity NPD7950 Approved
0.6906 Remote Similarity NPD7953 Approved
0.6906 Remote Similarity NPD7789 Approved
0.6906 Remote Similarity NPD7951 Approved
0.6906 Remote Similarity NPD7791 Approved
0.6905 Remote Similarity NPD7947 Clinical (unspecified phase)
0.6905 Remote Similarity NPD5421 Clinical (unspecified phase)
0.6904 Remote Similarity NPD7393 Clinical (unspecified phase)
0.6902 Remote Similarity NPD3833 Phase 3
0.6902 Remote Similarity NPD3835 Phase 3
0.6901 Remote Similarity NPD3794 Approved
0.6901 Remote Similarity NPD8488 Clinical (unspecified phase)
0.6901 Remote Similarity NPD8094 Discontinued
0.6901 Remote Similarity NPD3795 Approved
0.69 Remote Similarity NPD7175 Phase 1
0.6898 Remote Similarity NPD4326 Phase 2
0.6897 Remote Similarity NPD7406 Phase 2
0.6897 Remote Similarity NPD7944 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data